Prospective Evaluation of Asians With CRT for Heart Failure
NCT ID: NCT02814942
Last Updated: 2021-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2011-01-31
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methodology:Among patients undergoing CRT for severe heart failure according to indications stipulated in international Cardiology guidelines, baseline demographic data is collected. Age, gender, NYHA functional class, co-morbidities, QRS width on ECG, presence of left bundle branch block pattern on ECG, presence of atrial fibrillation, left ventricular ejection fraction (LVEF) on echocardiogram, ventricular dimensions, 6 min walk test distance are collected. In addition, during the CRT implant procedure, blood is drawn from the vascular access and analysed for NT-pro BNP levels and other biomarkers of heart failure.
The echocardiographic and ECG parameters and blood biomarkers are reanalysed at 6 months and 12 months following CRT implant. Response to CRT is defined as a reduction in the iLVESV (left ventricular end-systolic volume index to body surface area) of \>/= 15% and/or an increase in the LVEF of \>/= 10%.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Asian neTwork for Translational Research and Cardiovascular Trials ("ATTRaCT")
NCT02791009
Left Atrial Distensibility Guiding Management in Advanced Chronic Heart Failure
NCT01307722
Singapore Cardiac Longitudinal Outcomes Database
NCT03760705
Multi- Level and Integrated Analysis of Mechanisms Underlying Atrial Dysfunction
NCT02789943
The Bicuspid Aortic Stenosis Following Transcatheter Aortic Valve Replacement Registry
NCT02394184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heart Failure receiving CRT
Heart failure patients with QRS \> 120ms receiving CRT
Cardiac Resynchronization Therapy
Cardiac resynchronization therapy with or without ICD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac Resynchronization Therapy
Cardiac resynchronization therapy with or without ICD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* EF \< 40%
* Symptomatic heart failure
* Not on optimal medical therapy
Exclusion Criteria
* \< 18 years of age
* Infection
* Unable to consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University Heart Centre, Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pipin Kojodjojo
Consultant Cardiac Electrophysiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Swee Chong Seow, MD
Role: PRINCIPAL_INVESTIGATOR
National University Hospital, Singapore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National University Hospital
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Pipin Kojodjojo, MD PHD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Pipin Kojodjojo, MD PHD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/00608
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.